Angiotensin II receptor subtypes in the rat brain

Area of Science:

• Neuropharmacology
• Receptor Binding Assays
• Cardiovascular Research

Background:

• Angiotensin II (AII) plays a crucial role in regulating blood pressure and fluid balance.
• The existence and distribution of specific AII receptor subtypes in the brain are not fully elucidated.
• Understanding AII receptor subtypes is vital for developing targeted therapies for cardiovascular and neurological disorders.

Purpose of the Study:

• To characterize the binding sites of AII receptors in the rat brain.
• To differentiate between AII receptor subtypes using a selective antagonist, DuP 753.
• To correlate receptor subtype distribution with biochemical properties.

Main Methods:

• Utilized the non-peptide AII receptor antagonist, DuP 753, for competitive binding assays.
• Employed radioligand 125I-[Sar1,Ile8]AII (125I-SIAII) to quantify AII receptor binding.
• Investigated the effect of sulfhydryl reducing agents on AII receptor binding.

Main Results:

• DuP 753 selectively competed for 125I-SIAII binding in numerous rat brain nuclei with high affinity (IC50 = 20-30 nM).
• A subset of AII binding sites showed weak competition by DuP 753 (IC50 > 10(-4) M).
• DuP 753-sensitive sites (AII alpha) correlated with inhibition by sulfhydryl reducing agents, while DuP 753-insensitive sites (AII beta) did not.

Conclusions:

• The study successfully differentiated two AII receptor subtypes in the rat brain, designated AII alpha and AII beta.
• AII alpha receptors are characterized by sensitivity to DuP 753 and sulfhydryl reducing agents.
• AII beta receptors are insensitive to DuP 753 and sulfhydryl reducing agents, suggesting distinct molecular properties.